MILAN — Intercos Group’s founder and president Dario Ferrari has launched a latest skincare brand, dubbed DF18+.

The entrepreneur, who built an empire supplying beauty products to multinationals and emerging brands for the past 50 years, has quietly introduced his personal enterprise. This is supposed to be added to Intercos Group’s portfolio of greater than 550 international clients.

Made in Switzerland, the DF18+ lineup goals to simplify the skincare routine by offering high performance and technology through its plant-based formulations mixing 18 lively ingredients. These include patented technological actives, resembling Allure Vita, Bionymph Peptide, Cell Pulse and Vita Freeze with antiaging properties, to call just a few.

The corporate claims to be the primary out there to boast eight stem cell patented actives for skincare application in addition to to source lively ingredients from plant cell tissue and extracts via sustainable technology that minimizes natural impact, waste and water consumption.

The assortment includes six items that retail from $46 for the Halo Skintranslucent gel-like powder that may act as a primer, makeup base and fixing product to $168 for the Intensive Cream aimed toward skin’s cellular rejuvenation.

Other products include the antiaging Original Serum, the hydrating and pore refining Velvet Serum, the brightening Silk Serum and the lifting and replumping Balm Serum. The total line is available in minimal white bottles, mostly available in a 30-ml. size.

The DF18+ brand already has an e-commerce platform and quietly opened a physical outpost in Milan’s tony Via Santo Spirito, which the corporate dubbed as its clubhouse.

Adorned with displays designed in collaboration with creative director JoAnn Tan and an original Andy Warhol flower series hailing from Ferrari’s private art collection, the flagship offers the total product assortment and services resembling a skin evaluation test enabling customers to evaluate their skin condition and personalize their beauty treatment. Aimed toward monitoring the skin condition over time, the in-store device has dedicated programs for various areas and offers customized reports, statistics and pictures to visualise the progress before and after the DF18+ treatment. A skin evaluation service can be offered remotely with a web-based test.

Ten years within the making, DF18+ was inspired by Ferrari’s mother, doctor Nadja Avalle. A cosmetic innovator and entrepreneur, she moved to Switzerland and commenced a profession in cosmetic formulation, creating products for luxury brands. For one, she was a pioneer in repurposing flower residues from the perfume industry as raw materials for skincare within the ‘70s, and in 1979 she was elected president of IFCC, the International Federation of Clinical Chemistry and Laboratory Medicine. In 1983, Avalle created CRB, a specialist in skincare development and manufacturing, which was acquired by Intercos Group in 2006.

In response to the Italian newspaper Corriere della Sera, which first reported on the launch on Tuesday, DF18+ leverages technologies Intercos implemented with Arterra Bioscience through their three way partnership Vitalab, which dates back to 2010 and is devoted to the research and development of lively ingredients and naturally-derived ingredients based on stem cells, plants and algae, amongst others.

Each Intercos Group and Arterra are listed on the Italian Bourse, with the previous debuting on Euronext Milan last 12 months, just a few months after inking a five-year agreement with the University of Milano-Bicocca to jointly conduct scientific research on latest raw materials, formulations and sustainable processes aimed toward developing modern beauty products.

In the primary nine months of 2022 ended Sept. 30, Intercos Group’s revenues grew 23 percent to 597.1 million euros in comparison with the identical period last 12 months and were up 15 percent versus the identical period in 2019. Overall last 12 months the group had 673.7 million euros in revenues, up 11.1 percent versus 2020.